Gritstone bio IncNASDAQ:GRTSNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6104
- TODAY'S CHANGE (%)0.0305 (5.2595%)
- Bid / Lots0.6104/ 4
- Ask / Lots0.6153/ 7
- Open / Previous Close0.5884 / 0.5799
- Day Range
- 52 Week Range
- Volume2,122,996
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GRTS |
|---|---|---|
| 09:32 ET | 6108 | 0.5969 |
| 09:34 ET | 435 | 0.5925 |
| 09:36 ET | 1663 | 0.59595 |
| 09:38 ET | 6047 | 0.5965 |
| 09:39 ET | 9594 | 0.612 |
| 09:41 ET | 2890 | 0.612 |
| 09:43 ET | 7463 | 0.603 |
| 09:45 ET | 39397 | 0.5971 |
| 09:48 ET | 400 | 0.6002 |
| 09:50 ET | 1230 | 0.6033 |
| 09:52 ET | 850 | 0.597101 |
| 09:54 ET | 1300 | 0.5971 |
| 09:56 ET | 765 | 0.6001 |
| 09:57 ET | 866 | 0.600785 |
| 09:59 ET | 500 | 0.60175 |
| 10:01 ET | 4200 | 0.6003 |
| 10:03 ET | 7344 | 0.60515 |
| 10:06 ET | 17070 | 0.6099 |
| 10:08 ET | 2850 | 0.6097 |
| 10:10 ET | 500 | 0.6097 |
| 10:12 ET | 3994 | 0.60575 |
| 10:14 ET | 3200 | 0.6058 |
| 10:15 ET | 2700 | 0.6099 |
| 10:19 ET | 8747 | 0.6098 |
| 10:21 ET | 23224 | 0.6171 |
| 10:24 ET | 7655 | 0.6256 |
| 10:26 ET | 7123 | 0.63 |
| 10:28 ET | 3326 | 0.6295 |
| 10:30 ET | 11260 | 0.6384 |
| 10:32 ET | 7295 | 0.64 |
| 10:33 ET | 57964 | 0.6531 |
| 10:35 ET | 28632 | 0.6499 |
| 10:37 ET | 24617 | 0.6486 |
| 10:39 ET | 61246 | 0.66 |
| 10:42 ET | 108792 | 0.66935 |
| 10:44 ET | 54191 | 0.6629 |
| 10:46 ET | 199730 | 0.658882 |
| 10:48 ET | 25240 | 0.6656 |
| 10:50 ET | 94113 | 0.6684 |
| 10:51 ET | 84407 | 0.6603 |
| 10:53 ET | 70632 | 0.6488 |
| 10:55 ET | 108739 | 0.649 |
| 10:57 ET | 99291 | 0.6549 |
| 11:00 ET | 26691 | 0.6609 |
| 11:02 ET | 60141 | 0.665 |
| 11:04 ET | 72712 | 0.6608 |
| 11:06 ET | 23487 | 0.6669 |
| 11:08 ET | 19564 | 0.6641 |
| 11:09 ET | 68855 | 0.65485 |
| 11:13 ET | 500 | 0.6498 |
| 11:15 ET | 300 | 0.6599 |
| 11:18 ET | 3548 | 0.6499 |
| 11:20 ET | 1778 | 0.6499 |
| 11:22 ET | 410 | 0.6499 |
| 11:24 ET | 3037 | 0.6562 |
| 11:26 ET | 5599 | 0.6579 |
| 11:27 ET | 10312 | 0.6471 |
| 11:29 ET | 4100 | 0.6463 |
| 11:31 ET | 626 | 0.65 |
| 11:33 ET | 6413 | 0.64 |
| 11:36 ET | 60717 | 0.6212 |
| 11:38 ET | 33980 | 0.626551 |
| 11:40 ET | 10732 | 0.62655 |
| 11:42 ET | 1183 | 0.626601 |
| 11:44 ET | 7601 | 0.6239 |
| 11:45 ET | 8012 | 0.6167 |
| 11:47 ET | 42012 | 0.6112 |
| 11:49 ET | 9637 | 0.6141 |
| 11:51 ET | 5091 | 0.6052 |
| 11:54 ET | 11821 | 0.615199 |
| 11:56 ET | 4923 | 0.6021 |
| 11:58 ET | 4470 | 0.60175 |
| 12:00 ET | 15112 | 0.6092 |
| 12:02 ET | 11318 | 0.609249 |
| 12:03 ET | 5444 | 0.609249 |
| 12:05 ET | 954 | 0.6064 |
| 12:07 ET | 18084 | 0.6163 |
| 12:09 ET | 4230 | 0.6122 |
| 12:12 ET | 6994 | 0.6202 |
| 12:14 ET | 21832 | 0.6204 |
| 12:16 ET | 2300 | 0.6202 |
| 12:18 ET | 900 | 0.6184 |
| 12:20 ET | 6145 | 0.6176 |
| 12:21 ET | 6280 | 0.6089 |
| 12:23 ET | 611 | 0.6089 |
| 12:25 ET | 853 | 0.61 |
| 12:27 ET | 7444 | 0.6173 |
| 12:30 ET | 100 | 0.6186 |
| 12:32 ET | 309 | 0.6172 |
| 12:34 ET | 6589 | 0.6185 |
| 12:36 ET | 3101 | 0.6181 |
| 12:38 ET | 10943 | 0.6161 |
| 12:39 ET | 21063 | 0.61645 |
| 12:41 ET | 68487 | 0.6079 |
| 12:43 ET | 1147 | 0.6104 |
| 12:45 ET | 26481 | 0.6114 |
| 12:48 ET | 35795 | 0.6178 |
| 12:50 ET | 500 | 0.61285 |
| 12:52 ET | 2200 | 0.6132 |
| 12:54 ET | 7650 | 0.6136 |
| 12:56 ET | 10400 | 0.6136 |
| 12:57 ET | 4772 | 0.6136 |
| 12:59 ET | 4003 | 0.6156 |
| 01:01 ET | 2702 | 0.6134 |
| 01:03 ET | 6098 | 0.614 |
| 01:06 ET | 894 | 0.617 |
| 01:08 ET | 300 | 0.6102 |
| 01:10 ET | 352 | 0.6102 |
| 01:12 ET | 783 | 0.6178 |
| 01:14 ET | 300 | 0.6102 |
| 01:15 ET | 1953 | 0.615 |
| 01:17 ET | 2582 | 0.615 |
| 01:19 ET | 11150 | 0.6126 |
| 01:21 ET | 4572 | 0.6125 |
| 01:24 ET | 4000 | 0.6121 |
| 01:26 ET | 200 | 0.6108 |
| 01:28 ET | 100 | 0.6108 |
| 01:30 ET | 400 | 0.61425 |
| 01:32 ET | 500 | 0.6108 |
| 01:33 ET | 500 | 0.6143 |
| 01:35 ET | 300 | 0.6108 |
| 01:37 ET | 721 | 0.6177 |
| 01:39 ET | 902 | 0.6108 |
| 01:42 ET | 900 | 0.6108 |
| 01:44 ET | 200 | 0.6108 |
| 01:46 ET | 2048 | 0.6104 |
Today
The Schall Law Firm Provides Support To Investors To Spearhead The Securities Fraud Legal Action Against Gritstone Bio Inc, from 13 minutes ago by Dow Jones
13 minutes ago by Dow JonesShareholders that Lost Money on Gritstone bio, Inc.(GRTS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesAugust 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GRTS, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Gritstone bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRTS, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesGRTS Investors Have Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit, from 2 hours ago by Dow Jones
2 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Gritstone bio Inc | 63.0M | -0.4x | --- |
Celularity Inc | 64.0M | -0.3x | --- |
Carisma Therapeutics Inc | 47.8M | -0.6x | --- |
Turnstone Biologics Corp | 51.8M | -0.6x | --- |
Aligos Therapeutics Inc | 31.6M | -0.3x | --- |
ImmuCell Corp | 33.4M | -8.3x | --- |
Company Information
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. It has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate. In oncology, it develops personalized vaccines that aim to destroy tumors through CD8+ (killer) T cell recognition of tumor cells by virtue of their surface display of neoantigens.
Contact Information
- Headquarters
- 5959 HORTON STREET, SUITE 300EMERYVILLE, CA, United States 94608
- Phone
- 510-871-6100
- Fax
- 510-597-1488
Executives
- Independent Chairman of the Board
- Elaine Jones
- President, Chief Executive Officer, Director
- Andrew Allen
- Chief Financial Officer, Executive Vice President
- Vassiliki Economides
- Chief Operating Officer, Executive Vice President
- Erin Jones
- Executive Vice President, Chief Business Officer
- Matthew Hawryluk
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $63.0M |
|---|---|
Revenue (TTM) | $15.6M |
Shares Outstanding | 108.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-1.57 |
Book Value | $0.53 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 4.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -924.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
